Vivavoce
PrivateLast Round
VC Round
Oct 22, 2020
Est. Valuation
$3.48M
Total Funding Raised
$220,000
Company Overview
Vivavoce operates in Healthcare & Life Sciences and is based in Milan. Its latest recorded funding round was a VC Round in October 2020.
Vivavoce is a healthcare company that operates a medical center intended to diagnose and rehabilitate disorders related to voice, language, communication, and learning with a focus on stuttering.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Patient Engagement
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivavoce Comparables
Compare Vivavoce with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Keys Group | 65% | |
| BeneTalk Ltd | 56% | |
| Expressable | 54% |
For institutional investors. Book with your work email.
Vivavoce Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 22, 2020 | ||||
| Crowdfunding | Dec 30, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vivavoce Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEFEA Impact | VC Round |
| Opes Italia SICAF EuVECA | VC Round |
| Fondazione Social Venture Giordano Dell'Amore | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 35% MoM, reaching 19.5K.
- Apr 2, 2026
Monthly visitors increased 53% MoM, reaching 22K.
For institutional investors. Book with your work email.
Vivavoce Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vivavoce's valuation, stock price, and market status.
Is Vivavoce a public or private company?
Vivavoce is a private company.
What is the current stock price of Vivavoce?
Vivavoce is a private company, so its shares have no public market price. Caplight tracks Vivavoce's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivavoce worth (valuation)?
Vivavoce's valuation is estimated at $3.5M based on funding round data.
Can I buy Vivavoce stock?
Vivavoce shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivavoce's last funding round?
Vivavoce's most recent funding round was VC Round on October 22, 2020.
Who are the main investors in Vivavoce?
Key investors in Vivavoce include SEFEA Impact, Opes Italia SICAF EuVECA, Fondazione Social Venture Giordano Dell'Amore.
Will Vivavoce IPO soon?
No public IPO plans have been announced for Vivavoce.
How can I track Vivavoce secondary market activity?
Caplight tracks bids, offers, and trades in Vivavoce's shares on secondary markets.